INTRODUCTION
============

The ability of lipids, and specifically phosphoinositides (PIs), to regulate membrane homeostasis has been well established. Classically, PI-dependent regulation is associated with the recruitment of soluble proteins to membranes to promote the proteins' function. However, a growing body of work now shows that PIs and other regulatory lipids contribute to a wide array of functions including transcriptional regulation ([@B6]), protein sequestering to inhibit function ([@B52]), microdomain formation ([@B49]; [@B16]), modulating the physical properties of membranes ([@B1]; [@B56]), and regulating the activity of membrane-anchored proteins ([@B9]; [@B30]; [@B27]). The rapid modification of lipids by specific kinases, phosphatases, and lipases adds an additional layer of complexity by affecting the spatiotemporal control of cellular events. In the context of *Saccharomyces cerevisiae* vacuole homeostasis, two of the important PIs are PI3P and PI(3,5)P~2~. These lipids appear to play opposing roles, as PI3P is characterized as a positive regulator of fusion ([@B3]; [@B16]; [@B26]; [@B29]), whereas PI(3,5)P~2~ promotes vacuolar fission ([@B19]; [@B4]).

PI(3,5)P~2~ is found predominantly in the late endosome and vacuole, where it is made exclusively by the PI3P 5-kinase Fab1 ([@B55]; [@B19]). Deletion of *FAB1* results in a complete loss of PI(3,5)P~2~, as well as a drastic enlargement of the vacuole. PI(3,5)P~2~ can be dephosphorylated to PI3P by the PI(3,5)P~2~ 5-phosphatase Fig4 ([@B18]), yet the deletion of *FIG4* leads to an overall decrease in PI(3,5)P~2~ ([@B12],[@B13]; [@B14]). This is due to the required presence of Fig4 along with Vac7, Vac14, and Atg18 in the Fab1 complex to yield maximum activity ([@B47]; [@B5]; [@B23]).

The enlarged vacuolar phenotype seen with the loss of Fab1 suggested a role for PI(3,5)P~2~ in membrane fission. Further work showed that hypertonic conditions, which induce vacuolar fission, lead to a rapid increase in PI(3,5)P~2~ levels ([@B10]; [@B4]; [@B13]). The rise in PI(3,5)P~2~ triggers a release of Ca^2+^ through the exporter Yvc1 ([@B9]). Deletion of either Fab1 or Yvc1 attenuates the ability of hypertonic conditions to cause membrane fission, indicating that the increase in PI(3,5)P~2~ and subsequent release of Ca^2+^ are essential for membrane fission. PI(3,5)P~2~ also binds directly to the vacuole-specific V-ATPase V~O~ subunit Vph1 to trigger V-ATPase assembly ([@B30]). Vacuolar acidification itself has been shown to be an essential component of membrane fission, as inhibition of V-ATPase H^+^ pumping activity leads to fission defects ([@B2]). In this study we examined the ability of PI(3,5)P~2~ to regulate membrane fusion.

RESULTS AND DISCUSSION
======================

Dioctanoyl PI(3,5)P~2~ inhibits vacuole homotypic fusion
--------------------------------------------------------

Yeast vacuole fusion is promoted by a group of regulatory lipids including PI3P, PI4P, PI(4,5)P~2~, ergosterol, and diacylglycerol, whereas vacuole fission during hyperosmotic shock is regulated by the PI(3,5)P~2~ ([@B10]; [@B4]; [@B13]). PI(3,5)P~2~ is made sparingly and turned over rapidly, a likely indication that its prolonged presence or elevated concentration could have a negative impact on vacuole homeostasis. PI(3,5)P~2~ is also made under isotonic conditions, albeit at lower concentrations ([@B4]; [@B13]). Although much is known about PI(3,5)P~2~, its effect during vacuole fusion is unclear. Here we tested the effects of adding exogenous dioctanoyl (C8) PI(3,5)P~2~ to in vitro vacuole homotypic fusion reactions. We found that C8-PI(3,5)P~2~ inhibited vacuole fusion in a dose-dependent manner with an IC~50~ of ∼100 µM ([Figure 1A](#F1){ref-type="fig"}). The apparent IC~50~ includes the large fraction of the lipid that does not incorporate into the membrane. Others have found that 340 µM C8-PI(4,5)P~2~ is needed to reach 4 mol% incorporation into liposomes ([@B7]). Thus, we can roughly estimate that 100 µM C8-PI(3,5)P~2~ would translate to 1.2 mol% incorporated into vacuoles.

![Dioctanoyl lipids and vacuole homotypic fusion. WT (A) or *yvc1*Δ (B) vacuoles were tested for fusion with buffer alone or a dose-response curve of C8-PI(3,5)P~2~. (C) WT vacuole fusion in the presence of C8-PI3P. (D) WT vacuole fusion in the presence of C8-PI(3,5)P~2~ or C8-PI(4,5)P~2~. Error bars are SEM (*n* = 3). \*\**p \<* 0.01, \*\*\**p \<* 0.001 (unpaired *t* test).](mbc-30-201-g001){#F1}

During hyperosmotic shock, PI(3,5)P~2~ activates the TRP Ca^2+^ channel Yvc1. To test whether the inhibitory effect of PI(3,5)P~2~ was due to Yvc1 activation, we used vacuoles from *yvc1*Δ yeast. The addition of C8-PI(3,5)P~2~ to *yvc1*Δ vacuoles had an inhibitory effect on fusion nearly identical to that of WT vacuoles ([Figure 1B](#F1){ref-type="fig"}). Thus, we can conclude that the effect of C8-PI(3,5)P~2~ is independent of activating Yvc1 function. As a control we used the PI(3,5)P~2~ precursor PI3P. WT vacuoles were treated with a curve of C8-PI3P and tested for fusion. Unlike the inhibitory effects of PI(3,5)P~2~, there was no significant reduction in fusion with C8-PI3P ([Figure 1C](#F1){ref-type="fig"}). To see whether the inhibitory effect of PI(3,5)P~2~ was related to the presence of two phosphates on the head group, we used C8-PI(4,5)P~2~ in fusion assays. We found that C8-PI(4,5)P~2~ also inhibited vacuole fusion, albeit at a significantly higher concentration (IC~50~ \> 300 µM) relative to C8-PI(3,5)P~2~ ([Figure 1D](#F1){ref-type="fig"}). The difference in IC~50~ values was likely due to nonoverlapping sets of interacting partners. For instance PI(4,5)P~2~ interacts with twinfilin ([@B39]), cofilin ([@B38]), and Spo14 ([@B48]), while PI(3,5)P~2~ interacts with Vph1 ([@B30]), Ivy1 ([@B32]), Atg18 ([@B11]), and Yvc1 ([@B9]).

C8-PI(3,5)P~2~ inhibits vacuole fusion at the docking stage
-----------------------------------------------------------

Previously, we found that adding C8-phosphatidic acid (PA) inhibited vacuole fusion at the priming stage by preventing the recruitment of Sec18 to *cis*-SNARE complexes ([@B52]). To begin to determine at which stage PI(3,5)P~2~ inhibited fusion, we first tested SNARE priming. When Sec18 is recruited to inactive SNAREs for priming, it associates with *cis*-SNARE complexes through its interactions with Sec17. Once Sec18 hydrolyzes ATP to dissociate SNAREs, Sec17 is released from the membrane ([@B33]). Thus, priming can be measured by the loss of Sec17 from the membrane. Here, fusion reactions were incubated with reaction buffer, C8-PI(3,5)P~2~, or *N*-ethylmaleimide (NEM), a known inhibitor of priming ([@B40]). Individual reactions were incubated for specific times after which they were centrifuged to separate the membrane- bound (pellet) and solubilized (supernatant) fractions of Sec17. These experiments showed that PI(3,5)P~2~ did not negatively affect SNARE priming, as levels of Sec17 were released similar to those of the buffer control ([Figure 2, A and B](#F2){ref-type="fig"}). In contrast, SNARE priming was inhibited by NEM, as shown by the complete blocking of Sec17 release.

![C8-PI(3,5)P~2~ inhibits vacuole fusion at the docking stage. (A) WT vacuoles were monitored for Sec17 release of upon SNARE priming. Fusion reactions containing 3 µg of vacuoles were incubated with reaction buffer, 232 µM C8-PI(3,5)P~2~, or 1 mM NEM. Vacuoles were incubated at 27°C for the indicated times, after which the organelles were pelleted by centrifugation. Released proteins in the supernatant were separated from the membrane-bound fraction. The membrane pellets were resuspended in volumes of buffer equal to the supernatant. Sec17 was detected by immunoblotting and the amount released was calculated by densitometry. (B) Normalized values were averaged and plotted over time of incubation. (C) Gain-of-resistance kinetic vacuole-fusion assays were performed in the presence of reaction buffer, 70 µg/ml anti-Sec18 IgG, 2 µM GDI, or C8-PI(3,5)P~2~. Reactions were incubated at 27°C. Reactions were treated with reagents or shifted to ice at the indicated time points. Fusion inhibition was normalized to the reactions receiving buffer alone. (D) Calculated half-times of resistance from assays in C. (E) Vacuole fusion reactions were incubated with anti-Sec17 IgG to block SNARE priming. After incubation for 15 min at 27°C, select reactions were further treated with either reaction buffer, GDI, or C8-PI(3,5)P~2~ and incubated for an additional 70 min. One reaction remained on ice for the duration of the assay. Reactions were then processed for glutathione pull down of GST--Vam7 protein complexes. Isolated protein complexes were immunoblotted for the presence of the SNAREs Vam3 and Nyv1. (F) Quantitation of SNARE complex formation in the presence or absence of C8-PI(3,5)P~2~. Error bars are SEM (*n* = 3).](mbc-30-201-g002){#F2}

To further resolve at which stage PI(3,5)P~2~ inhibited fusion, we performed a temporal-gain-of-resistance assay ([@B44]). Here, inhibitors were added to individual reactions at different time points throughout the incubation period. Fusion reactions become resistant to a reagent once the target of the inhibitor completes its function. Thus, inhibitors of early events (e.g., priming) would lose their effects before inhibitors of later stages (e.g., hemifusion). Through this approach, we found that PI(3,5)P~2~ inhibited fusion late in the docking stage, as its resistance curve was after the anti-Sec18 immunoglobulin G (IgG) priming inhibition curve and the tethering inhibitor GDI ([Figure 2, C and D](#F2){ref-type="fig"}). GDI extracts the Rab Ypt7 during fusion to prevent tethering and prevents the formation of *trans*-SNARE pairs ([@B21]). The uninhibited control was normalized to 1 for each time point. These data indicate that PI(3,5)P~2~ inhibits vacuole fusion after Ypt7-dependent vacuole association.

C8-PI(3,5)P~2~ does not inhibit *trans*-SNARE complex formation
---------------------------------------------------------------

Owing to the indication that PI(3,5)P~2~ inhibited vacuole fusion after tethering, we next examined whether SNARE complex formation occurred. For this, we used our GST--Vam7 bypass assay, where fusion reactions are blocked at the priming stage by anti-Sec17 IgG ([@B26]; [@B36]). The added GST--Vam7 forms new *trans* complexes with free SNAREs ([@B34]; [@B54]). Between the addition of anti-Sec17 and Vam7, we further treated individual reactions with GDI or PI(3,5)P~2~. Once GST--Vam7 was added, the reactions were incubated at 27°C or on ice as indicated. After incubation, the reactions were placed on ice and solubilized as described in *Materials and Methods*. GST--Vam7 SNARE complexes were isolated with reduced glutathione beads and SNARE complexes were detected by immunoblotting. [Figure 2E](#F2){ref-type="fig"} shows that GST--Vam7 formed complexes with its cognate SNAREs Vam3 and Nyv1 when incubated at 27°C, whereas remaining on ice prevented complex formation. While GDI reduced SNARE complex formation, the addition of PI(3,5)P~2~ had no effect on the interactions of these proteins. Quantitation of multiple experiments showed that PI(3,5)P~2~ indeed had no significant effect on SNARE pair formation ([Figure 2F](#F2){ref-type="fig"}).

Lipid mixing is blocked by C8-PI(3,5)P~2~
-----------------------------------------

Previous studies have shown that lysophosphatidylcholine (LPC) blocked fusion late in the pathway, with a gain-of-resistance curve similar to what we saw with PI(3,5)P~2~ ([@B43]). While LPC permitted SNARE complex assembly, it was shown that LPC blocked hemifusion (outer leaflet lipid mixing) in a dose-dependent manner. We next examined whether PI(3,5)P~2~ had an effect similar to that of LPC in blocking outer leaflet lipid mixing after allowing *trans*-SNARE complex formation. Lipid mixing was measured by the dequenching of Rhodamine-PE (Rh-PE) on the outer leaflets of vacuoles. Rh-PE--labeled vacuoles were incubated with an excess of unlabeled vacuoles. Upon the fusion of the outer leaflets, Rh-PE was diluted to restore fluorescence. Our results showed that PI(3,5)P~2~ potently blocked lipid mixing, similarly to what was seen with LPC ([Figure 3, A and B](#F3){ref-type="fig"}). As a negative control, we used GDI to block fusion at the tethering stage. These data indicate that PI(3,5)P~2~ blocks fusion at a stage after *trans*-SNARE pairing but before lipid mixing can occur.

![Lipid mixing is blocked by C8-PI(3,5)P~2~. (A) Lipid-mixing assay measuring outer leaflet fusion, that is, hemifusion, were performed using vacuoles labeled with Rh-PE. Reactions were treated with either buffer, GDI, or C8-PI(3,5)P~2~ and incubated for 40 min. Reactions were started by adding ATP after 5 min. Fluorescence was measured every 60 s and plotted against time as a percent of maximum fluorescence. (B) Quantitation of average maximum Rh-PE fluorescence. Error bars are SEM (*n* = 3).](mbc-30-201-g003){#F3}

Fab1 mutants affect lipid mixing
--------------------------------

To verify that an excess of PI(3,5)P~2~ inhibits lipid mixing, we used vacuoles from yeast expressing the hyperactive kinase mutation *fab1^T2250A^* ([@B28]). As predicted, *fab1^T2250A^* vacuoles failed to undergo lipid mixing ([Figure 4, A and B](#F4){ref-type="fig"}). This was attributed to the increased production of PI(3,5)P~2~ and is consistent with our data using exogenous lipid. This posed the question of whether lowering free PI(3,5)P~2~ on *fab1^T2250A^* vacuoles would restore lipid mixing. To this aim we used the PI(3,5)P~2~ probe ML1-N, a polypeptide region at the N-terminus of the endolysosomal the TRPML Ca^2+^ channel ([@B9]). We found that added 50 nM ML1-N partially restored lipid mixing ([Figure 4J](#F4){ref-type="fig"}). This further supports the model in which an excess of free PI(3,5)P~2~ negatively regulates vacuole fusion.

![Fab1 mutants block lipid mixing. Lipid-mixing assays were performed with WT, *fab1^T2250A^* (A, B), *fab1^EEE^* (C, D), or *fig4*Δ (E, F) vacuoles. Reactions were started with the addition of ATP after 5 min and incubated for 60 min. Fluorescence was measured every 60 s. B, D, and F show quantitation of average maximum Rh-PE fluorescence. (G) WT and *fig4*Δ vacuoles were treated with C8-PI(3,5)P~2~ and tested for lipid mixing. (H) Comparison of the inhibitory effects of C8-PI(3,5)P~2~ on lipid mixing. The inhibition of WT vacuole lipid mixing by C8-PI(3,5)P~2~ was normalized to 1 and compared with the relative inhibition of *fig4*Δ vacuole lipid mixing. (I) *fab1^EEE^* vacuoles were treated with C8-PI(3,5)P~2~ and tested for lipid mixing. The amount of lipid mixing at the end of 60 min in the absence of C8-PI(3,5)P~2~ was normalized to 1 and compared with the relative results in the presence of C8-PI(3,5)P~2~ at the indicated concentrations. Data are represented as whisker plots. (J) *fab1^T2250A^* vacuoles were treated with ML1-N and tested for lipid mixing. The terminal level of lipid mixing in the untreated sample was normalized to 1 and compared with the relative results in the presence of ML1-N. (K) Analysis of fusion factors on purified vacuoles (5 µg protein) from WT, *fab1*^EEE^, or *fab1^T2250A^* yeast. Antibodies against the indicated proteins were used for immunoblotting. Error bars are SEM (*n* = 3). \**p \<* 0.5.](mbc-30-201-g004){#F4}

We next tested whether the lack of PI(3,5)P~2~ would have the opposite effect on lipid mixing. To check this, we used vacuoles from yeast with the kinase dead mutant *fab1^EEE^* ([@B30]). Although we expected to find elevated lipid mixing relative to WT vacuoles, we found that *fab1^EEE^* vacuoles were blocked for lipid mixing ([Figure 4, C and D](#F4){ref-type="fig"}). This suggests that some PI(3,5)P~2~ production is needed for fusion, but an excess is inhibitory, which is consistent with a biphasic role for the lipid in vacuole fusion. Biphasic roles for lipids are not unusual. For instance, PI(4,5)P~2~ is needed for fusion, yet an excess of the lipid has an inhibitory effect. Another example lies in the turnover of PI(4,5)P~2~ by phospholipase C (Plc1) to make diacylglycerol. It was shown that while low levels of Plc1 enhanced fusion, excess Plc1 blocked fusion altogether ([@B25]).

Finally, we used *fig4*Δ vacuoles, which produce reduced amounts of PI(3,5)P~2~ in comparison with WT cells. We found that *fig4*Δ vacuoles showed a modest reduction in lipid mixing ([Figure 4, E and F](#F4){ref-type="fig"}). This suggests that the reduced PI(3,5)P~2~ levels associated with *fig4*Δ cells are sufficient to support lipid mixing, albeit at reduced efficiency. Together, these data suggest that the transition from docking to the hemifusion stage requires some Fab1 activity, but augmented PI(3,5)P~2~ production is inhibitory.

To further test the effects of modulating PI(3,5)P~2~ concentrations on lipid mixing, we asked whether adding C8-PI(3,5)P~2~ to *fab1^EEE^* or *fig4*Δ vacuoles would restore lipid mixing. When *fig4*Δ vacuoles were treated with 25, 50, or 100 µM C8-PI(3,5)P~2~ we found that lipid mixing was inhibited. However, when they were compared with WT, we discovered that the inhibitory power of C8-PI(3,5)P~2~ was not as potent with *fig4*Δ vacuoles ([Figure 4G](#F4){ref-type="fig"}). Comparison of the changes in lipid mixing due to 100 µM C8-PI(3,5)P~2~ showed an ∼50% reduction in lipid mixing inhibition of *fig4*Δ vacuoles ([Figure 4](#F4){ref-type="fig"}H). This was not due to complete blocking of lipid mixing, as it can be further inhibited at higher C8-PI(3,5)P~2~ concentrations ([Figure 3](#F3){ref-type="fig"}). We attribute the reduced inhibition of *fig4*Δ vacuole lipid mixing to the reduced endogenous levels of PI(3,5)P2 associated with the deletion. Thus, the combined amount of endogenous and C8-PI(3,5)P~2~ in *fig*4Δ vacuoles was less than ino WT vacuoles, resulting in different effects. This also shows that sufficient endogenous PI(3,5)P~2~ is present on isolated vacuoles to affect fusion efficiency.

In parallel, we found that adding C8-PI(3,5)P~2~ had no effect on *fab1^EEE^* lipid mixing ([Figure 4J](#F4){ref-type="fig"}). The lack of any rescue suggested that other factors could be affected by the lack of Fab1 activity. Western blotting of known fusion factors on isolated vacuoles showed that Sec17 and Mon1 were reduced on both *fab1^EEE^* and *fab1^T2250A^* vacuoles ([Figure 4K](#F4){ref-type="fig"}). Sec17 is needed for SNARE priming ([@B33]), while Mon1 is the guanine nucleotide exchange factor or the Rab Ypt7 ([@B37]). In addition, *fab1^EEE^* vacuoles contained reduced levels of Ycf1, an ABC transporter needed for efficient vacuole fusion ([@B45]). A reduction in any of these factors could be expected to affect lipid mixing negatively. Other key factors such as SNAREs, HOPS, or Ypt7 were not altered on these vacuoles, and the normal amount of Ypt7 suggested that sufficient Mon1 was present to recruit the Rab. It should be noted that these blots were not comprehensive and there could be further changes in protein sorting in *fab1^EEE^* and *fab1^T2250A^* that could alter vacuole homeostasis.

Endogenous PI(3,5)P~2~ on isolated vacuoles and fusion
------------------------------------------------------

Thus far, our studies show that while high levels of PI(3,5)P~2~ potently inhibit fusion, lower concentrations are in fact beneficial for fusion. To further investigate this, we used the PI(3,5)P~2~ ligand ML1-N described above. We added a curve of purified GST-ML1-N to fusion reactions and found that fusion was completely blocked ([Figure 5A](#F5){ref-type="fig"}). This suggests that the endogenous vacuolar PI(3,5)P~2~ plays a positive role in the fusion pathway.

![Endogenous PI(3,5)P~2~ on isolated vacuoles. (A) WT vacuoles were incubated with ML1-N to bind PI(3,5)P~2~. (B) Docking reactions of vacuoles incubated with Cy3-ML1-N. Vacuoles were counterstained with the MDY-64 to label the entirety of the membranes. Representative vacuole clusters are shown for qualitative assessment of PI(3,5)P~2~ distribution.](mbc-30-201-g005){#F5}

To visualize endogenous levels of vacuolar PI(3,5)P~2~, we used Cy3-labeled GST-ML1-N to perform docking experiments. Here we used WT, *fab1^EEE^*, and *fab1^T2250A^* vacuoles. Cy3-ML1-N was added to vacuoles incubated for 20 min at 27°C to allow docking. After incubation, vacuoles were stained with MDY-64 and examined by fluorescence microscopy. Equal exposure times were used for each strain. Z-stacks of images were taken for ten fields per strain and deconvolved using Zeiss Axiovision software. [Figure 5B](#F5){ref-type="fig"} shows equatorial images of docked vacuoles. WT vacuoles were stained with Cy3-ML1, which clustered at the junctions where vacuoles come into contact, similarly to the localization of other regulatory lipids as previously shown ([@B16]). *Fab1^EEE^* vacuoles showed no staining whatsoever, in keeping with the lack of kinase activity. This also illustrates the specificity of Cy3-ML1 for PI(3,5)P~2~, as other PIs such as PI3P and PI(4,5)P~2~ are present in the absence of Fab1 activity ([@B19]). It is also important to note that *fab1^EEE^* vacuoles were commonly enlarged and deformed, as exemplified by the selected cluster (asterisk). This is in agreement with the enlarged vacuoles seen in *fab1*Δ cells. Finally, we observed increased Cy3-ML1 staining on *fab1^T2250A^* vacuoles, as expected in the presence of elevated PI(3,5)P~2~. Interestingly, we also observed an increase in small vesicles with increased Cy3-ML1-N staining tightly apposed to larger vacuoles. Although further detailed testing would be required to verify it, these small vesicles could be the result of vacuole fission linked to the hyperactive nature of this mutant.

Taken together, the results of this study have demonstrated that while PI(3,5)P~2~ is needed for vacuole fusion, an excess of the lipid strongly blocks the system. This leaves us with the question of how PI(3,5)P~2~ directly affects fusion. One possible mechanism for the inhibition of fusion could be linked to the vacuolar ATPase. Others have reported that PI(3,5)P~2~ stabilizes the interactions of the V~1~ and V~O~ components of the V-ATPase ([@B30]). This occurs through the direct interactions of the V~O~ subunit Vph1 and PI(3,5)P~2~, which promote binding of the V~1~ complex. The increased assembly of the V~1~--V~O~ holoenzyme would in turn deplete free V~O~ complexes on the vacuole membrane. The significance of altering the levels of free V~O~ complexes and vacuole fusion lies in the ability of V~O~ complexes to interact in *trans* between apposed membranes. Mayer and colleagues originally found that the formation of *trans* V~O~--V~O~ complexes plays a role in membrane fusion ([@B42]). Since their discovery, several other groups using various systems found that V~O~ plays important noncanonical roles in membrane fusion, including the release of insulin ([@B53]), phagosome--lysosome fusion ([@B41]), and the release of exosomes through the fusion of multivesicular bodies with the plasma membrane ([@B31]). The c-rings of the V~O~ also interact in *trans* between membranes to form conductance channels through their proteolipid pores ([@B8]). Although PI(3,5)P~2~ has not been shown to reduce V~O~--V~O~ *trans* complexes directly, it stands to reason that the increase in V~1~--V~O~ complexes would in turn diminish the former and potentially alter fusion efficiency.

Another potential target for PI(3,5)P~2~ could involve altering Ca^2+^ transport across the vacuole membrane. During salt shock, PI(3,5)P~2~ is rapidly synthesized and interacts with the TRP channel Yvc1 to release vacuolar Ca^2+^ stores. Because vacuolar Ca^2+^ stores are also released in response to the formation of *trans*-SNARE pairs ([@B34]), we initially hypothesized that PI(3,5)P~2~ could affect fusion through interactions with Yvc1. However, vacuoles from *yvc1*Δ yeast were equally susceptible to PI(3,5)P~2~ relative to the WT parents, suggesting that PI(3,5)P~2~ has a different target for the inhibition of fusion. Taken together with the studies on PI(3,5)P~2~ and vacuole fission, we propose that this lipid performs two opposing functions as a molecular switch to go between fission and fusion.

MATERIALS AND METHODS
=====================

Reagents
--------

Soluble reagents were dissolved in PIPES--sorbitol (PS) buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol) with 125 mM KCl unless indicated otherwise. Anti-Sec17 IgG, anti-Sec18 and Pbi2 (Protease B inhibitor) were prepared as described previously ([@B22]; [@B33]; [@B50]). C8-PI3P (1,2-dioctanoyl-phosphatidylinositol 3-phosphate) and C8-PI(4,5)P~2~ (1,2-dioctanoyl-phosphatidylinositol 3,5-bisphosphate) were purchased from Echelon. Recombinant GST--Vam7 and GDI were prepared as previously described ([@B15]; [@B17]; [@B51]). Plasmid to produce recombinant GST-ML1-N was a gift from H. Xu (University of Michigan). GST-ML1-N was prepared as described and dialyzed against PS buffer with 125 mM KCl ([@B9]). Lissamine Rhodamine (Rh-PE) was from ThermoFisher. NEM (N-ethylmaleimide) was from Sigma.

Strains
-------

BJ3505 ([@B24]) and DKY6281 ([@B20]) were used for fusion assays (Table S1 in the Supplemental Material)*. YVC1* was deleted by homologous recombination using PCR products amplified from pFA6-KanMX6 with the primers 5′-YVC1-KO and 3′-YVC1-KO with homology flanking the *YVC1* coding sequence (Table S2 in the Supplemental Material). The PCR product was transformed into BJ3505 and DKY6281 yeast by standard lithium acetate methods and plated on YPD media containing G418 (250 µg/ml) to generate BJ3505 *yvc1*Δ*::kanMX6* (RFY74) and DKY6281 *yvc1*Δ*::kanMX6* (RFY75). Similarly, *FAB1* was deleted by recombination using the primers 5′-FAB1-KO and 3′-FAB1-KO to generate BJ3505 *fab1*Δ*::kanMX6* (RFY76). RFY76 was transformed with a plasmid encoding the hyperactive kinase mutant *fab1^T2250A^* (pRS416-FAB1-T2250A) and grown in selective media lacking uracil to make RFY78 ([@B28]). Similarly, a plasmid encoding the kinase--dead mutant *fab1^EEE^* (pRS416-FAB1-EEE) was transformed into RFY76 to make RFY80 ([@B30]). Plasmids harboring Fab1 mutants were a gift from Lois Weisman (University of Michigan). *FIG4* was deleted through recombination as described above, using PCR products amplified from pAG32 with the primers 5′-FIG4-KO and 3′-FIG4-KO to generate BJ3505 *fig4*Δ*::hphMX4* (RFY82). Transformants were grown in YPD with hygromycin (250 µg/ml).

Vacuole isolation and in vitro fusion assay
-------------------------------------------

Vacuoles were isolated as described ([@B20]). In vitro fusion reactions (30 µl) contained 3 µg each of vacuoles from BJ3505 (*PHO8 pep4*Δ) and DKY6281 (*pho8*Δ *PEP4*) backgrounds, reaction buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol, 125 mM KCl, 5 mM MgCl~2~), ATP regenerating system (1 mM ATP, 0.1 mg/ml creatine kinase, 29 mM creatine phosphate), 10 µM CoA, and 283 nM Pbi2. Fusion was determined by the processing of pro-Pho8 (alkaline phosphatase) from BJ3505 by the Pep4 protease from DK6281. Fusion reactions were incubated at 27°C for 90 min and Pho8 activity was measured in 250 mM Tris-HCl, pH 8.5, 0.4% Triton X-100, 10 mM MgCl~2~, and 1 mM *p*-nitrophenyl phosphate. Pho8 activity was stopped after 5 min by addition of 1 M glycine, pH 11, and fusion units were measured by determining the *p-*nitrophenolate produced by detecting absorbance at 400 nm.

GST--Vam7 SNARE complex isolation
---------------------------------

SNARE complex isolation was performed as described previously using GST--Vam7 ([@B15]; [@B17]; [@B36], [@B35]). Briefly, 5× fusion reactions were incubated with 85 µg/ml anti-Sec17 IgG to block priming. After 15 min, 2 µM GDI or 232 µM C8-PI(3,5)P~2~ was added to selected reactions and incubated for an additional 5 min before the addition of 150 nM GST--Vam7. After a total of 90 min, reactions were sedimented (11,000 × *g*, 10 min, 4°C), and the supernatants were discarded before the extraction of vacuoles with solubilization buffer (SB: 20 mM HEPES-KOH, pH 7.4, 100 mM NaCl, 2 mM EDTA, 20% glycerol, 0.5% Triton X-100, 1 mM dithiothreitol) with protease inhibitors (1 mM PMSF, 10 µM Pefabloc-SC, 5 µM pepstatin A, and 1 µM leupeptin). Vacuole pellets were overlaid with 100 µl SB and resuspended gently. An additional 100 µl SB was added, gently mixed, and incubated on ice for 20 min. Insoluble debris was sedimented (16,000 × *g*, 10 min, 4°C) and 176 µl of supernatants was removed and placed in chilled tubes. Next, 16 µl was removed from each reaction as 10% total samples, mixed with 8 µl of 3X SDS loading buffer, and heated (95°C, 5 min). Equilibrated glutathione beads (30 µl) were incubated with the remaining extracts (15 h, 4°C, nutation). Beads were sedimented and washed 5× with 1 ml SB (735 × *g*, 2 min, 4°C), and bound material was eluted with 40 µl 1× SDS loading buffer. Protein complexes were examined by Western blotting.

Lipid mixing
------------

Lipid mixing assays were conducted using rhodamine B DHPE (Rh-PE; Thermo-Fisher) as described ([@B44],[@B46], [@B45]; [@B36], [@B35]; [@B26]). BJ3505 vacuoles (300 µg) were isolated and then incubated in 400 µl of PS buffer containing 150 µM Rh-PE (10 min, 4°C, nutating). Next, 800 µl of 15% Ficoll was added and then transferred to an 11 × 60 mm ultracentrifuge tube, overlaid with 1.2 ml of 8 and 4% and 0.5 ml of PS buffer. Labeled vacuoles were isolated by centrifugation (105,200 × *g*, 25 min, 4°C, SW-60 Ti rotor) and recovered from the 0--4% Ficoll interface. Lipid mixing assays (90 µl) contained 2 µg of labeled vacuoles and 16 µg of unlabeled vacuoles in fusion buffer. Reaction mixtures were transferred to a black, half-volume 96-well flat-bottom microtiter plate (Corning 3686) on ice. The plate was transferred to a fluorescence plate reader at 27°C to start the reactions. Measurements were taken every 60 s for 40 min, yielding fluorescence values (λ~ex~ = 544 nm; λ~em~ = 590 nm) at the onset (*F*~0~) and during the reaction (*F~t~*). After 40 min, 0.45% (vol/vol) Triton X-100 was added and the final 10 measurements were averaged to give the value of fluorescence after infinite dilution (*F*~TX100~). The relative fluorescence change Δ*F~t~*/*F*~TX100~ = (*F~t~* -- *F*~0~)/*F*~TX100~ -- *F*~0~ was calculated.

Vacuole docking
---------------

Docking reactions (30 µl) containing 6 µg of vacuoles from WT, *fab1^EEE^, fab1^T2250A^*, or *fig4*Δ yeast were incubated in docking buffer (20 mM PIPES-KOH, pH 6.8, 200 mM sorbitol, 100 mM KCl, 0.5 mM MgCl~2~), ATP regenerating system (0.3 mM ATP, 0.7 mg/ml creatine kinase, 6 mM creatine phosphate), 20 μM CoA, and 283 nM Pbi2 ([@B16]). PI(3,5)P~2~ was labeled with 2.5 µM Cy3-GST-ML1-N. Reactions were incubated at 27°C for 20 min. After incubation, reaction tubes were placed on ice and vacuoles were stained with 1 µM MDY-64. Reactions were next mixed with 50 μl of 0.6% low-melt agarose (in PS buffer), vortexed to disrupt nonspecific clustering, and mounted on slides for observation by fluorescence microscopy. Images were acquired using a Zeiss Axio Observer Z1 inverted microscope equipped with an X-Cite 120XL light source, a Plan Apochromat 63X oil objective (NA 1.4), and an AxioCam CCD camera.
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diC8

:   dioctanoyl

GDI

:   GDP dissociation inhibitor

HOPS

:   homotypic fusion and vacuole protein sorting complex

PA

:   phosphatidic acid

PI

:   phosphatidylinositol

PI3P

:   phosphatidylinositol 3-phosphate

PI(3,5)P ~2~

:   phosphatidylinositol 3,5-bisphosphate

SNARE

:   soluble *N*-ethylmaleimide--sensitive factor attachment protein receptor
